These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2871096)

  • 41. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and laboratory studies of nosocomial Staphylococcus aureus resistant to methicillin and aminoglycosides.
    Bock BV; Pasiecznik K; Meyer RD
    Infect Control; 1982; 3(3):224-8. PubMed ID: 6920362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention and drug therapy of methicillin resistant Staphylococcus aureus infections].
    Matsumoto K; Nagatake T
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):289-92. PubMed ID: 2332683
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of methicillin-resistant Staphylococcus aureus infections.
    Med Lett Drugs Ther; 1982 Dec; 24(624):107-8. PubMed ID: 6924065
    [No Abstract]   [Full Text] [Related]  

  • 45. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growing clinical significance of methcillin-resistant Staphylococcus aureus.
    Benner EJ; Kayser FH
    Lancet; 1968 Oct; 2(7571):741-4. PubMed ID: 4175546
    [No Abstract]   [Full Text] [Related]  

  • 47. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic susceptibility patterns of respiratory isolates of Staphylococcus aureus in a Turkish university hospital.
    Gonlugur U; Akkurt I; Ozdemir L; Bakici MZ; Icagasioglu S; Gultekin F
    Acta Microbiol Pol; 2003; 52(2):143-8. PubMed ID: 14594401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Hessen MT; Pitsakis PG; Kaye D
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1143-5. PubMed ID: 2393273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.
    Schentag JJ; Hyatt JM; Carr JR; Paladino JA; Birmingham MC; Zimmer GS; Cumbo TJ
    Clin Infect Dis; 1998 May; 26(5):1204-14. PubMed ID: 9597254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms.
    Jones SM; Morgan M; Humphrey TJ; Lappin-Scott H
    Lancet; 2001 Jan; 357(9249):40-1. PubMed ID: 11197363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vancomycin therapy of severe staphylococcal infections.
    Kirby WM
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():73-8. PubMed ID: 6394579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill].
    Selva O'Callaghan A; San José Laporte A; Almirante Gragera B; Vilardell Tarrés M
    Med Clin (Barc); 1998 May; 110(17):678. PubMed ID: 9656216
    [No Abstract]   [Full Text] [Related]  

  • 54. The demise of the 'old' methicillin-resistant Staphylococcus aureus.
    Jepsen OB
    J Hosp Infect; 1986 Mar; 7 Suppl A():13-7. PubMed ID: 2871093
    [No Abstract]   [Full Text] [Related]  

  • 55. Methicillin-resistant staphylococci: a sign of the times?
    McDonald PJ
    Med J Aust; 1982 May; 1(11):445-6. PubMed ID: 7099073
    [No Abstract]   [Full Text] [Related]  

  • 56. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
    Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance of methicillin-resistant staphylococcus aureus to third-generation cephalosporins.
    Collins JK; Mader JT; Kelly MT
    J Infect Dis; 1983 Mar; 147(3):591. PubMed ID: 6550616
    [No Abstract]   [Full Text] [Related]  

  • 59. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections.
    Rahman M
    J Antimicrob Chemother; 1998 Mar; 41(3):325-8. PubMed ID: 9578158
    [No Abstract]   [Full Text] [Related]  

  • 60. Methicillin-resistant staphylococci.
    Lancet; 1968 Oct; 2(7571):759. PubMed ID: 4175555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.